medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Март 6, 2024
ABSTRACT
Within
a
multi-state
viral
genomic
surveillance
program,
we
conducted
case-control
analysis
comparing
prior
receipt
of
XBB.1.5-adapted
mRNA
vaccination
between
SARS-CoV-2-infected
adults
with
inpatient/ED
visits
(proxy
for
severe
illness)
vs
outpatient
visits.
Among
6,551
patients
from
September
2023-January
2024,
6.1%
12.0%
had
received
XBB.1.5
(aOR=0.41;
95%CI:0.32-0.53).
This
protective
association
was
weaker
among
JN.1
(aOR=0.62;
95%CI:0.40-0.96)
XBB-lineage
(aOR=0.28;
95%CI:0.18-0.43)
variant
infections
(interaction,
p=0.003).
also
specifically
compared
to
BA.4/BA.5-adapted
(aOR=0.60;
95%CI:0.45-0.79).
vaccines
protect
against
illness,
but
protection
may
be
variants.
Reviews in Medical Virology,
Год журнала:
2022,
Номер
32(5)
Опубликована: Июль 20, 2022
Abstract
The
first
dominant
SARS‐CoV‐2
Omicron
variant
BA.1
harbours
35
mutations
in
its
Spike
protein
from
the
original
that
emerged
late
2019.
Soon
after
discovery,
rapidly
to
become
worldwide
and
has
since
evolved
into
several
variants.
is
of
major
public
health
concern
owing
high
infectivity
antibody
evasion.
This
review
article
examines
theories
have
been
proposed
on
evolution
including
zoonotic
spillage,
infection
immunocompromised
individuals
cryptic
spread
community
without
being
diagnosed.
Added
complexity
Omicron's
are
multiple
reports
recombination
events
occurring
between
co‐circulating
variants
with
Delta
other
such
as
XE.
Current
literature
suggests
combination
novel
resulted
having
higher
than
Wuhan‐Hu‐1
variant.
However,
severity
believed
be
less
reduced
syncytia
formation
lower
multiplication
human
lung
tissue.
Perhaps
most
challenging
studies
indicate
efficacy
available
vaccines
against
(8–127
times
reduction)
compared
administration
booster
vaccine,
however,
compensates
reduction
improves
by
12–35
fold.
Concerningly
though,
broadly
neutralising
monoclonal
antibodies,
those
approved
FDA
for
therapeutic
use
previous
variants,
mostly
ineffective
exception
Sotrovimab
recent
suggest
BA.2
also
resistant
Sotrovimab.
Currently
two
new
BA.4
BA.5
emerging
reported
more
transmissible
immunity
generated
antibodies.
As
will
likely
continue
emerge
it
important
evolution,
biological
consequences
mutations,
existing
well
understood.
Viruses,
Год журнала:
2022,
Номер
14(6), С. 1239 - 1239
Опубликована: Июнь 7, 2022
Recombination
is
a
common
evolutionary
tool
for
RNA
viruses,
and
coronaviruses
are
no
exception.
We
review
here
the
evidence
recombination
in
SARS-CoV-2
reconcile
nomenclature
recombinants,
discuss
their
origin
fitness,
speculate
how
recombinants
could
make
difference
future
of
COVID-19
pandemics.
Vaccines,
Год журнала:
2022,
Номер
10(11), С. 1926 - 1926
Опубликована: Ноя. 14, 2022
The
world
has
not
yet
completely
overcome
the
fear
of
havoc
brought
by
SARS-CoV-2.
virus
undergone
several
mutations
since
its
initial
appearance
in
China
December
2019.
Several
variations
(i.e.,
B.1.616.1
(Kappa
variant),
B.1.617.2
(Delta
B.1.617.3,
and
BA.2.75
(Omicron
variant))
have
emerged
throughout
pandemic,
altering
virus's
capacity
to
spread,
risk
profile,
even
symptoms.
Humanity
faces
a
serious
threat
as
long
keeps
adapting
changing
fundamental
function
evade
immune
system.
Delta
variant
two
escape
alterations,
E484Q
L452R,
well
other
mutations;
most
notable
these
is
P681R,
which
expected
boost
infectivity,
whereas
Omicron
about
60
with
certain
deletions
insertions.
40-60%
more
contagious
comparison
Alpha
variant.
Additionally,
AY.1
lineage,
also
known
"Delta
plus"
variant,
surfaced
result
mutation
was
one
causes
life-threatening
second
wave
coronavirus
disease
2019
(COVID-19).
Nevertheless,
recent
variants
represent
reminder
that
COVID-19
epidemic
far
from
ending.
sparked
fervor
investigation
on
why
initially
appeared
propagate
so
much
rapidly
than
three
concerns
(VOCs),
whether
it
threatening
those
ways,
how
type
mutations,
induce
minor
changes
proteins,
can
wreck
trouble.
This
review
sheds
light
pathogenicity,
treatments,
impact
vaccine
efficacy
Cell Insight,
Год журнала:
2022,
Номер
1(3), С. 100029 - 100029
Опубликована: Май 2, 2022
The
emergence
of
the
SARS-CoV-2
Omicron
variant
poses
a
striking
threat
to
human
society.
More
than
30
mutations
in
Spike
protein
severely
compromised
protective
immunity
elicited
by
either
vaccination
or
prior
infection.
persistent
viral
evolutionary
trajectory
generates
Omicron-associated
lineages,
such
as
BA.1
and
BA.2.
Moreover,
virus
recombination
upon
Delta
co-infections
has
been
reported
lately,
although
impact
remains
be
assessed.
This
minireview
summarizes
characteristics,
evolution
mutation
control,
immune
evasion
mechanisms
variants,
which
will
helpful
for
in-depth
understanding
variants
policy-making
related
COVID-19
pandemic
control.
Nature Communications,
Год журнала:
2022,
Номер
13(1)
Опубликована: Окт. 23, 2022
Abstract
From
December
2021-February
2022,
an
intense
and
unprecedented
co-circulation
of
SARS-CoV-2
variants
with
high
genetic
diversity
raised
the
question
possible
co-infections
between
how
to
detect
them.
Using
11
mixes
Delta:Omicron
isolates
at
different
ratios,
we
evaluated
performance
4
sets
primers
used
for
whole-genome
sequencing
developed
unbiased
bioinformatics
method
detection
involving
genetically
distinct
lineages.
Applied
on
21,387
samples
collected
6,
2021
February
27,
2022
from
random
genomic
surveillance
in
France,
detected
53
The
prevalence
Delta
Omicron
(BA.1)
lineages
BA.1
BA.2
were
estimated
0.18%
0.26%,
respectively.
Among
6,242
hospitalized
patients,
intensive
care
unit
(ICU)
admission
rates
1.64%,
4.81%
15.38%
Omicron,
Delta/Omicron
No
BA.1/BA.2
reported
among
ICU
admitted
patients.
co-infected
a
total
21
patients
(39.6%)
not
vaccinated.
Although
rare
this
study,
their
proper
is
crucial
evaluate
clinical
impact
risk
emergence
potential
recombinants.
Clinical Microbiology and Infection,
Год журнала:
2022,
Номер
28(11), С. 1503.e5 - 1503.e8
Опубликована: Июль 2, 2022
To
describe
Delta/Omicron
SARS-CoV-2
variants
co-infection
detection
and
confirmation
during
the
fifth
wave
of
COVID-19
pandemics
in
France
7
immunocompetent
epidemiologically
unrelated
patients.
Genes,
Год журнала:
2023,
Номер
14(2), С. 407 - 407
Опубликована: Фев. 4, 2023
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
produced
diverse
molecular
variants
during
its
recent
expansion
in
humans
that
caused
different
transmissibility
and
severity
of
the
associated
disease
as
well
resistance
to
monoclonal
antibodies
polyclonal
sera,
among
other
treatments.
In
order
understand
causes
consequences
observed
SARS-CoV-2
diversity,
a
variety
studies
investigated
evolution
this
virus
humans.
general,
evolves
with
moderate
rate
evolution,
10
International Journal of Medical Sciences,
Год журнала:
2023,
Номер
20(1), С. 151 - 162
Опубликована: Янв. 1, 2023
The
SARS-CoV-2
Omicron
is
currently
the
predominant
circulating
variant
in
COVID-19
pandemic.
dominating
sublineages
respond
to
host
immune
pressure
and
develop
advantageous
mutations
or
genetic
recombination,
which
result
variants
that
are
more
contagious
better
at
escaping
responses
response
previous
infection
vaccination.
Meanwhile,
multiple
recombination
events
have
been
reported
coinfection
cases,
majority
of
resulted
from
between
co-circulating
BA.1
(or
BA.1.1)
Delta
BA.2.
Here,
we
review
knowledge
characterization
for
population
level,
provide
an
update
on
occurrence
newly
sublineages,
discuss
effectiveness
novel
vaccines/therapeutic
drugs
against
variant.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Янв. 15, 2024
Abstract
Systematic
monitoring
of
SARS-CoV-2
co-infections
between
different
lineages
and
assessing
the
risk
intra-host
recombinant
emergence
are
crucial
for
forecasting
viral
evolution.
Here
we
present
a
comprehensive
analysis
more
than
2
million
raw
read
datasets
submitted
to
European
COVID-19
Data
Portal
identify
recombination.
Co-infection
was
observed
in
0.35%
investigated
cases.
Two
independent
procedures
were
implemented
detect
We
show
that
sensitivity
is
predominantly
determined
by
density
lineage-defining
mutations
along
genome,
thus
used
an
expanded
list
mutually
exclusive
defining
specific
variant
combinations
increase
statistical
power.
call
attention
multiple
challenges
rendering
detection
difficult
provide
guidelines
reduction
false
positives
arising
from
chimeric
sequences
produced
during
PCR
amplification.
Additionally,
three
recombination
hotspots
Delta
–
Omicron
BA.1
recombinants.